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Obstructive diseases of the ureter are associated numerous deleterious effects including severe pain, inflammation, hypercontractility, cell proliferation, and potentially, cell transformation. (Gulmi et al, 1998; Weiss, 2002 ) Ureteral obstruction has a lifetime incidence of 13%, and total societal costs associated with diagnosis, treatment, pain management, and lost wages totals over $2 billion annually. (Clark et al; Romello et al, 2000) There is a substantial gap in the knowledge of the physiological changes that occur during ureteral obstruction, and this has limited the development of superior pharmacologic agents for symptomatic treatment of the disease. Because of this, narcotics remain first line therapy for treatment of symptomatic ureteral obstruction despite serious side effects and addictive concerns.
Prostanoids are critical to the physiological effects associated with ureteral obstruction. (Cole et al, 1988) The rate-limiting step in prostanoid synthesis is conversion of arachidonic acid to prostaglandin (PG) G 2 and subsequent conversion to PGH 2 . (Foegh et al, 1999) This reaction is catalyzed by cyclooxygenase (COX), an enzyme that exists in two isoforms: COX-1 and COX-2. (Kujuba et al, 1991 ) COX-1 is present in most human tissues, and although COX-1 expression can be regulated, it is usually considered to be expressed constitutively. (Foegh et al, 1999 ) COX-2 is present in most tissues at low levels but is substantially induced by local inflammatory and physical stimuli in addition to its homeostatic role.
Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit prostanoid synthesis and are used effectively to treat the pain and inflammation associated with urological obstruction. (Basar et al, 1991) However, NSAIDs cause gastric ulceration, inhibit platelet aggregation, and impair renal function. (Colletti et al, 1999; Oren and Ligumsky, 1994) Selective COX-2 blockade is an This article has not been copyedited and formatted. The final version may differ from this version.
Molecular Pharmacology Fast Forward. Published on October 9, 2007 as DOI: 10.1124/mol.107.035519 at ASPET Journals on November 7, 2017 molpharm.aspetjournals.org Downloaded from MOL #35519 5 intriguing therapy for symptoms of urinary tract obstruction because these medications provide potent analgesia with fewer toxic side effects than non-selective COX inhibitors. (Lanza et al, 1999 ) However, selective COX-2 inhibitors are also associated with renal side effects, particularly during ureteral obstruction when renal function is compromised. (Brune and Neubert, 2001; Hernandez et al, 2002) In addition, COX-2 inhibition is associated with cardiovascular side effects and clotting in susceptible individuals. (Mukherjee et al, 2001 ) Elucidation of cellular mechanisms that couple distention of the urinary tract with increased COX-2 activity may identify targets of drug action directed specifically at COX-2 induction.
In vivo obstruction and distension induces COX-2 expression in the urinary bladder, ureter, and kidney. (Park et al, 1998; Nakada et al, 2002; Chou et al, 2003) Further, mechanical stretch induces COX-2 expression in numerous cell culture models including vascular endothelial cells, osteoblasts and renal podocytes. (Fitzgerald et al, 2004; Inoue et al, 2002; Martineau et al, 2004) In addition, we have recently reported a cell culture model of urothelial cell stretch-induced COX-2 expression, and found that stretch-induced COX-2 expression is regulated at both transcriptional and post-transcriptional levels. (Jerde et al, 2006) We seek to determine the cellular mechanosensitive pathways in urothelial cells responding to during stretch that result in COX-2 induction. Deciphering the signaling mechanisms will assist in the identification of novel drug targets for the treatment of symptomatic urological obstructions. Stretch-activated calcium flux is believed to be a trigger in cellular stretch signaling. (Hamill et al, 2001 ) A primary effect of calcium signaling is activation of protein kinase C (PKC) signaling and recent reports have implicated PKC as critical in This article has not been copyedited and formatted. The final version may differ from this version. major groups: classical (α, β1, β2, γ); novel (δ, ε, η, θ); atypical (ζ, ι/λ); and mu (µ). (Newton, 1995) Upon activation by calcium, classical PKC isoforms migrate to the plasma membrane or nucleus and are active as kinases. (Newton, 1995) The purpose of this study is to determine if cell stretch induces calcium flux and PKC activation (translocation), and to determine if these signaling intermediates are involved in stretch-induced COX-2 expression.
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MATERIALS AND METHODS

Pharmacologic agents and chemicals
Ham's F12 nutrient medium, streptomycin/penicillin, fetal bovine serum, L-glutamine, glucose, transferrin, nonessential amino acids, and Trypsin-EDTA were purchased from SigmaAldrich (St. Louis, MO). Fura-2 AM, Fura-2, and the medium calcium removal kit were purchased from Molecular Probes (La Jolla, CA). BAPTA-AM, bisindolylmaleimide-1, myristoylated PKC pseudosubstrate peptide, and KT-5720 were purchased from Calbiochem (La Jolla, CA). GAPDH monoclonal antibody was purchased from Abcam (Cambridge, MA) and COX-2 monoclonal antibody was purchased from Cayman Chemical (Ann Arbor, MI).
Polyclonal antibodies to all PKC isoforms were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies to Nuclear Lamin B1 and Lactate Dehydrogenase were purchased from Abcam (Cambridge, MA) and the adenylyl cyclase activity assay was purchased from Molecular Devices, Sunnyvale, CA.
Isolation and culture of primary urothelial cells.
We isolated and grew primary urothelial cells in culture as previously described. (Teng et al, 2002 ) Briefly, we obtained fresh human ureteral segments and placed them in supplemented Ham's F12 nutrient medium (Sigma-Aldrich, St. Louis, MO) with 5% (v/v) fetal bovine serum (FBS, Sigma), 5 µg/ml apo-transferrin (Sigma), 2.7 mg/ml glucose (Sigma), 0.1 mM nonessential amino acids (Sigma), 100 U/ml penicillin, 100 µg/ml streptomycin (Sigma), and 2
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This article has not been copyedited and formatted. The final version may differ from this version. for 1 hour, and the above calcium concentration methodology was applied to the cells to determine the calcium response after 1 hour of cyclic stretch.
The effect of calcium chelation on stretch-induced COX-2 expression
Primary urothelial cells were plated on 6-well Bioflex (Flexcell Int.) tissue culture plates as described above and incubated in supplemented Ham's F12 growth medium overnight, to 80-90% confluency. The cells were incubated with supplemented Ham's F12 containing 0.3, 1, 3, 10, 30, or 100 µM BAPTA-AM or 0.1% DMSO (vehicle) for 30 minutes. The plates were placed on the cell stretch apparatus (FX-3000T; FlexCell); version 3.2 Tension Plus software was used to control the apparatus. Tension (stretch) was applied to the bottom of the flexible stretch membranes by pressure driven posts, controlled by the software. We stretched the cells to 20% increase in cell surface area using cyclic stretch at a rate of 12 cycles per minute for 6 hours, as this was previously determined to produce optimal induction of COX-2 expression. 
Stretch-induced protein kinase C activation
Primary urothelial cells were plated in 6-well Bioflex collagen-coated tissue culture plates as described above and incubated in supplemented Ham's F12 growth medium overnight, to 80-90% confluency. To determine the presence of PKC isoforms, cells were stretched for 30, 45, 60, 90 or 120 minutes and immunoblotted for PKC α, β1, β2, γ, δ, ε, θ, η, λ/ι, and ζ isoforms. It was determined that human urothelial cells highly expressed PKCα, β, and ζ, exhibited little expression of δ, ε, η, and λ/ι and β2, γ, and θ were undetectable. It was also determined that PKCα, β, and ζ were down regulated beyond 60 minutes of stretch. Based on these preliminary findings, we sought to determine the activation of PKCα, β, and ζ by measuring translocation to plasma membrane and nucleus after 45 minutes of stretch. For all experiments, unstretched cells and cells treated with 1 µM phorbol myristyl acetate (phorbol ester, PMA) were used as negative and positive controls, respectively.
To isolate the plasma membrane, we stretched 4, 6-well plates (approximately 10 8 cells) as described, washed once with PBS, and collected them in TEDK (10 mM Tris-HCl (pH 7.2), 0.3M KCl, 1mM EDTA, 5 mM DTT+1x protease inhibitor cocktail) with a cell scraper. We homogenized the cells with 40 strokes of a Dounce homogenizer, centrifuged the suspension at 500G for 10 minutes to pellet the nuclei, and collected the supernatant. The supernatant was centrifuged 27,000xG for 30 minutes to collect membrane and organelles. The resulting pellet was This article has not been copyedited and formatted. The final version may differ from this version. with Nonidet P40 at a final concentration of 0.6% and vortexing for 20 seconds at highest speed.
The suspension was centrifuged at 7200xG for 2 minutes to pellet the nuclei, and the pellet was Protein extracts from all three fractions were quantified and immunoblotted for PKC isoforms α, β1, and ζ. Fraction purity for cytosolic and nuclear protein extraction was assessed by immunoblotting each fraction for lactate dehydrogenase (exclusively cytosolic protein) and nuclear lamin B1 (exclusively nuclear protein) using the immunoblotting methods described.
Plasma membrane fraction purity was assessed by assaying each fraction for adenylyl cyclase activity (exclusively plasma membrane protein) using an activity assay (Molecular Devices, Sunnyvale, CA) in which protein extract from each fraction was assessed for its ability to generate cAMP from ATP in conditions recommended by the manufacturer.
The effect of Protein kinase C inhibition on stretch-induced COX-2 expression
Primary urothelial cells were plated on 6-well Bioflex tissue culture plates as described above and incubated in supplemented Ham's F12 growth medium overnight, to 80-90%
confluency. The cells were incubated with supplemented Ham's F12 containing 1, 10, or 100 nM bisindolylmaleimide-1; 3, 10, or 30 µM myristylated PKC pseudosubstrate peptide, or 0.1% DMSO (vehicle) for 1 at a rate of 12 cycles per minute for 6 hours, as previously described.
Unstretched cells were used as controls. After conclusion of the 6-hour stretch period, protein collections were assayed for COX-2 and GAPDH protein by immunoblotting.
This article has not been copyedited and formatted. The final version may differ from this version. such that the final dilution in the wells was 10 µl Oligofectamine TM per ml of medium and either 250 nM PKCα siRNA, 500 nM PKCβ1siRNA, or 500 nM PKCζ siRNA. These were the transfection conditions determined to be optimal in preliminary experiments. The transfections were allowed to progress for 48 hours; this time point was determined to be optimal in preliminary experiments. Additional cells were transfected with negative control RNA previously shown to not silence any gene in the human genome (Dharmacon), and untransfected cells were used as a second negative control. After the 48-hour transfection period, the cells were harvested and protein extracts were immunoblotted for GAPDH, COX-2, PKCα, PKCβ1, and PKCζ, as described above. PKC expression knockdown was determined by measuring densitometry of each PKC band relative to its GAPDH loading control and compare this to cells transfected with negative control RNA. 
Calcium dependence of PKCζ activation
In order to examine the interrelationship of the critical PKC isoform and calcium in stretch-induced COX-2 induction, we sought to determine if PKCζ activation was dependent on calcium. First, activation of the zeta isoform of PKC was determined by phosphorylation of threonine residues 403 and 410, by phospho-specific antibody (Abcam). Cells were stretched for 0.5, 1, 2, and 4 hours with 20% cyclic stretch (12 cycles per minute), total cell protein extract was collected, and phosphorylation of PKCζ was determined by immunoblotting. After confirming that optimal induction occurred within 2 hours of stretch, cells were incubated with supplemented Ham's F12 containing 3, 10, or 30 µM BAPTA-AM or 0.1% DMSO (vehicle) for 30 minutes. Cells were stretched for 1 hour with 20% cyclic stretch (12 cycles per minute), and total cell protein extract was collected in the presence of protease and phosphatase inhibitors.
Immunoblotting for phospho-(Thr 403/410) PKCζ activation was determined by immunoblotting by phospho-specific antibody.
This article has not been copyedited and formatted. The final version may differ from this version. (m/c: p=0.01; n/c: p=0.003) but not ζ (m/c: p=0.80; n/c: p=0.85). We verified cell fraction purity by blotting for lactate dehydrogenase (a cytosolic protein) and nuclear lamin B1 (a nuclear protein), and assessing adenylyl cyclase activity (plasma membrane protein). These data indicate that PKC is activated and translocated to the plasma membrane and nuclear region during cell stretch.
The effect of pharmacologic PKC inhibition on stretch-induced COX-2 expression:
DISCUSSION
Our data indicate that calcium and PKCα, β1, and ζ are induced by cell stretch in primary human urothelial cells. In addition, our data indicate that calcium and PKCζ are necessary for COX-2 expression in this model, and suggest that PKCα may play a secondary role. This is the first report specifically linking PKCζ to mechanically induced COX-2 expression. While other studies have used pharmacologic inhibitors to determine that PKC isoforms are involved in mechanotransduction involving vascular endothelial cells, and bone cells, this is the first study that we are aware of that uses siRNA targeting to specifically silence expression of the PKCζ isoform. This is also the first report to illustrate specific PKC isoform activation in response to cell stretch. Although PKCζ has been implicated in COX-2 induction in overexpression studies (Miller et al, 1997) , this is the first report identifying calcium and PKC as being integral to stretch-induced COX-2 expression in urothelial cells, the primary prostaglandin producing cells in the urinary tract, particularly as it relates to the pathophysiology of ureteral obstruction. (Ali et al, 1998) Our previous work illustrates the reproducibility and reliability of the urothelial cell We did not expect PKCζ to be the primary isoform of PKC involved in stretch-induced COX-2 expression, and it was even more unexpected that PKCα would have such a minimal effect. Our data clearly show the dependence of COX-2 induction on calcium, yet PKCζ is a calcium-independent isoform of PKC. Our data show that PKCζ activation, as measured by phosphorylation, is dependent upon available calcium in our system. However, the questions of how and to what extent PKCζ might be dependent on calcium in cell biology are unresolved in by our study, and were not the intent of our study. This effect could be direct or indirect, and future work will be directed at answering these important questions. While little is known regarding PKCζ activation, there is evidence that phosphoinositide-dependent kinase (PDK)-1 phosphorylates and activates PKCζ secondary to phosphoinositol triphosphate kinase (PI 3 K) signaling. (Hirai et al, 2003) Recent evidence from bone cells indicates this is a calcium driven process, (Danciu et al, 2003) and extracellular matrix proteins, all which may be modulated by calcium and PKC. (Santen et al, 2002; Appleby et al, 1994; Yamamoto et al, 1995; Tamura et al, 2002; Di Mari et al, 2003) However, most of these studies involved hormone or mitogen-induced conditions and data investigating mechanosensing pathways of COX-2 induction remain sparse. Stretch-induced COX-2 expression in bladder smooth muscle, renal podocytes, and osteoblasts does appear to be mitogen-activated protein (MAP) kinase-dependent, especially with regard to p38. (Fitzgerald et al, 2004; Martineau et al, 2004; Naruse et al, 2003) In addition, deletion analysis of COX-2 promoter elements has determined the importance of C/EBPβ, CRE, and AP-1 elements in shear stress-induced COX-2 expression in murine osteoblasts. (Ogasawara et al, 2001 ) However, the triggering cascades of these molecules are yet to be determined in mechanically stimulated cells.
The cellular mechanisms by which stretch induces COX-2 expression are an active area of This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. 
